CHICAGO — Anti-TNF biologic therapies are typically used first foradults aged 60 years or older with rheumatoid arthritis (RA), but many will need to switch to non-TNF biologics because of inadequate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results